Skip to main content

Table 1 The observed allele frequency (AF) and heterozygous frequency (HF) compared to the non-Finnish Europeans from the gnomAD database

From: Pathogenic variants carrier screening in New Brunswick: Acadians reveal high carrier frequency for multiple genetic disorders

Genes

Variants

AF Acadian sample

AF gnomAD NFE

AF ratio (Acadian/NFE)

HF Acadian Sample

HF gnomAD NFE

HF Ratio (Acadian/NFE)

Adj. p values

ABCC8

c.2252_2253dup

0.00833

NA

NA

0.01667

NA

NA

NA

ACADM

c.199T > C

0.00833

0.00102

8.2

0.01667

0.00203

8.2

1.000

ACADM

c.250C > T

0.00833

0.00012

67.2

0.01667

0.00025

67.2

0.486

AGL

c.18_19del

0.00833

0.00009

89.7

0.01667

0.00019

89.7

0.372

AIRE

c.967_979del

0.03333

0.00096

34.6

0.06667

0.00193

34.6

< 0.001

BBS1

c.1169T > G

0.00833

0.00277

3.0

0.01667

0.00555

3.0

1.000

BCHE

c.293A > G

0.07500

0.01766

4.2

0.15000

0.03439

4.4

0.009

CDH23

c.5371G > T

0.00833

NA

NA

0.01667

NA

NA

NA

CERKL

c.847C > T

0.00833

0.00054

15.5

0.01667

0.00108

15.5

1.000

CYP21A2

c.293-13C > T

0.00833

NA

NA

0.01667

NA

NA

NA

CYP27B1

c.262del

0.00833

0.00009

97.3

0.01667

0.00017

97.3

0.369

CYP27B1

c.1319_1325dup

0.00833

0.00017

48.8

0.01667

0.00034

48.7

0.658

DHCR7

c.964NA1G > C

0.00833

0.00608

1.4

0.01667

0.01216

1.4

1.000

DPYD

c.1905 + 1G > A

0.00833

0.00566

1.5

0.01667

0.01130

1.5

1.000

DPYD

c.2846A > T

0.02500

0.00516

4.8

0.05000

0.01029

4.9

0.771

ETFDH

c.51dup

0.01667

0.00014

119.3

0.03333

0.00028

119.3

0.005

FANCG

c.1480 + 1G > C

0.00833

0.00004

189.6

0.01667

0.00009

189.6

0.195

FMR1

47 CGG repeats

0.01667

NA

NA

0.03333

NA

NA

NA

GJB2

c.35del

0.00833

0.00958

0.9

0.01667

0.01903

0.9

1.000

LAMB3

c.2842del

0.00833

0.00004

215.2

0.01667

0.00008

215.2

0.172

MMACHC

c.331C > T

0.00833

0.00009

89.3

0.01667

0.00019

89.3

0.374

MPL

c.305G > C

0.00833

0.00071

11.7

0.01667

0.00142

11.7

1.000

MTHFR

c.665C > T

0.08333

0.33800

0.2

0.10000

0.44324

0.2

1.000

MTHFR

c.1286A > C

0.01667

0.31730

0.1

0.03333

0.42937

0.1

1.000

NPHS2

c.686G > A

0.05000

0.03099

1.6

0.06667

0.06938

1.0

1.000

PYGM

c.148C > T

0.00833

0.00252

3.3

0.01667

0.00503

3.3

1.000

RAPSN

c.133G > A

0.01667

0.00007

238.9

0.03333

0.00014

238.9

0.001

SERPINA1

c.863A > T

0.09167

0.03668

2.5

0.18333

0.06973

2.6

0.149

SLC12A3

c.248G > A

0.00833

0.00003

268.4

0.01667

0.00006

268.4

0.144

SLC17A5

c.533del

0.00833

0.00010

82.8

0.01667

0.00020

82.7

0.401

SLC17A5

c.819 + 1G > A

0.01667

0.00001

1884.1

0.03333

0.00002

1884.0

< 0.001

SLC17A5

c.918T > G

0.02500

0.00004

645.7

0.05000

0.00008

645.6

< 0.001

SMN1

Absence of SMN1

0.00833

NA

NA

0.01667

NA

NA

NA

USH2A

c.2276G > T

0.00833

0.00142

5.9

0.01667

0.00283

5.9

1.000

USH2A

c.4338_4339del

0.00833

0.00001

944.2

0.01667

0.00002

944.2

0.066

VPS13B

c.6002del

0.00833

0.00002

358.4

0.01667

0.00005

358.4

0.115

  1. Frequency ratio for each variant was calculated using the ratio of frequencies from the sample group and gnomAD Non-Finnish Europeans. Fisher’s one-tailed exact test adjusted using Bonferroni correction